
Glenview Capital, a major shareholder of CVS Health, is reportedly meeting with the leadership of the company on Monday to discuss some fixes to resolve the struggles of the healthcare firm.
The hedge fund has a sizeable stake in the company and it also is invested in Teva Pharmaceuticals and Centene, CNBC reported